IDiyas

For the Inventor, By the Inventor

Needham Heights, MA, United States of America

Binyuan Sun

USPTO Granted Patents = 16

 

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Chestnut Hill, MA (US) (2012 - 2016)
  • Boston, MA (US) (2010 - 2017)
  • Needham Heights, MA (US) (2014 - 2022)

Company Filing History:

goldMedal12 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal2 out of 2 
 
Novacyte Therapeutics Company., Ltd
 patents
bronzeMedal1 out of 40 
 
Merck Canada Inc.
 patents
4. 1 out of 2,961 
 
Harvard College
 patents
5. 1 out of 1 
 
Novacyte, Inc.
 patent
where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):
1. 12343399 - Polymer linkers and their uses (2025-07-01),
2. 11529422 - Polymer linkers and their uses (2022-12-20),
3. 10583196 - Polymer linkers and their uses (2020-03-10),
4. 9775839 - 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors (2017-10-03),
5. 9682978 - 2,6,7 substituted purines as HDM2 inhibitors (2017-06-20),
6. 9540377 - 2,6,7,8 substituted purines as HDM2 inhibitors (2017-01-10),
7. 9351965 - Indazole derivatives useful as ERK inhibitors (2016-05-31),
8. 9242984 - Pyrazolyl derivatives as Syk inhibitors (2016-01-26),
9. 9206142 - Anilinopiperazine derivatives and methods of use thereof (2015-12-08),
10. 8999957 - Heterocyclic compounds as ERK inhibitors (2015-04-07),
11. 8962611 - Substituted imidazopyridines as HDM2 inhibitors (2015-02-24),
12. 8846657 - Substituted imidazopyridines as HDM2 inhibitors (2014-09-30),
13. 8609675 - Fused Tricyclic Compounds as novel mTOR inhibitors (2013-12-17),
14. 8591943 - Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors (2013-11-26),
15. 8318735 - 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors (2012-11-27),

Title: The Innovations of Inventor Binyuan Sun

Introduction

Binyuan Sun, an accomplished inventor based in Needham Heights, MA, has made significant contributions to the field of drug delivery systems. With a total of 15 patents to his name, he is known for his expertise in developing innovative solutions that enhance the efficacy of medical treatments.

Latest Patents

Among his notable recent inventions, Binyuan Sun has patented methods for creating polymer linkers and their applications. One key focus of his latest patents involves poly-1-hydroxymethylethylene hydroxymethyl formal (PHF)-based drug delivery systems. He has also developed methods for making antibody-drug conjugates, which play a crucial role in modern therapeutic approaches, as well as methods of treatment utilizing these conjugates.

Career Highlights

Binyuan Sun has worked with prominent pharmaceutical companies, including Merck Sharp & Dohme Corporation and Merck Canada Inc. His career is marked by a dedication to advancing pharmaceutical technologies and improving patient outcomes through innovative drug delivery mechanisms.

Collaborations

Throughout his career, Sun has collaborated with talented colleagues, such as Gerald Wayne Shipps, Jr. and Michelle R Machacek. These partnerships have fostered a collaborative environment that encourages creative solutions and the shared goal of advancing health care through innovation.

Conclusion

Binyuan Sun stands out as a visionary inventor whose work in drug delivery systems is paving the way for new treatment strategies. With a robust portfolio of patents and a commitment to collaboration, he continues to influence the pharmaceutical industry with his innovative ideas and practical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…